A New Paradigm in Managing Advanced Ovarian Cancer: Differentiating Patients Requiring Neoadjuvant Treatment from Primary Cytoreduction

SIMPLE SUMMARY: This study evaluates the comparability of patients treated with primary cytoreduction and patients undergoing neoadjuvant chemotherapy for advanced stages high grade serous ovarian carcinoma by comparing the preoperative and postoperative characteristics after a propensity score matc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraus, Francois, El Hajj, Houssein, Le Deley, Marie-Cécile, Aissaoui, Othman, Gachon, Bertrand, Chevalier, Annick, Abdeddaim, Cyril, Lemaire, Anne-Sophie, Ben Haj Amor, Mariem, Sylla, Dienabou, Leblanc, Eric, Narducci, Fabrice, Hudry, Delphine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508489/
https://www.ncbi.nlm.nih.gov/pubmed/34638409
http://dx.doi.org/10.3390/cancers13194925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508489/
https://www.ncbi.nlm.nih.gov/pubmed/34638409
http://dx.doi.org/10.3390/cancers13194925

Ejemplares similares